S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
Omicron exposes inflexibility of Europe's public hospitals
Serbia votes in referendum on constitutional changes
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
Omicron exposes inflexibility of Europe's public hospitals
Serbia votes in referendum on constitutional changes
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
Omicron exposes inflexibility of Europe's public hospitals
Serbia votes in referendum on constitutional changes
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
Tesla inks deal to get key battery component outside China
In California pot market, a hazy line between legal and not
South Korean president visits UAE, showcasing deep ties
Rising costs add to pandemic pain for small businesses
The 5 Easiest To-Use Calendar Apps for Modern Day Working Adults
Omicron exposes inflexibility of Europe's public hospitals
Serbia votes in referendum on constitutional changes
NASDAQ:THRN

Thorne Healthtech News Headlines

$6.41
+0.08 (+1.26%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.17
▼
$6.45
50-Day Range
$5.26
▼
$10.00
52-Week Range
$5.20
▼
$10.13
Volume
81,206 shs
Average Volume
237,947 shs
Market Capitalization
$336.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Thorne Healthtech News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRN and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Thorne Healthtech Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

THRN
News Sentiment
▼
-0.76

0.31
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

THRN Articles
This Week
▼
1

0
▲
THRN Articles
Average Week



Thorne Healthtech (NASDAQ:THRN) News Headlines Today

SourceHeadline
marketbeat.com logoThorne Healthtech (NASDAQ:THRN) Lowered to Hold at Zacks Investment Research
marketbeat.com - January 13 at 7:06 AM
finance.yahoo.com logoWhat Kind Of Investors Own Most Of Thorne HealthTech, Inc. (NASDAQ:THRN)?
finance.yahoo.com - December 23 at 10:28 AM
nasdaq.com logoThorne Healthtech Inc Shares Fall 1.5% Below Previous 52-Week Low - Market Mover
nasdaq.com - December 22 at 8:28 AM
finance.yahoo.com logoThorne HealthTech's First-of-Its-Kind 'Wellth Report' Reveals Shifts in Individuals' Health Behaviors with Ripple Effects for the Healthcare Industry and Broader Workforce
finance.yahoo.com - December 16 at 1:58 PM
finance.yahoo.com logoThorne HealthTech to Present at 4th Annual Evercore ISI HealthCONx Conference
finance.yahoo.com - November 22 at 8:40 AM
finance.yahoo.com logoThorne HealthTech to Host Third Quarter 2021 Earnings Conference Call
finance.yahoo.com - October 25 at 6:30 PM
finance.yahoo.com logoThorne HealthTech Announces Closing of its Initial Public Offering
finance.yahoo.com - September 29 at 4:00 PM
Get Thorne Healthtech News Delivered to You Automatically

Sign up to receive the latest news and ratings for THRN and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.